Cargando…

Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes

Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Dingyuan, Huang, Xiaoxi, Geng, Jing, Dong, Run, Li, Shuhong, Liu, Zheng, Wang, Chen, Dai, Huaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085113/
https://www.ncbi.nlm.nih.gov/pubmed/27203210
http://dx.doi.org/10.18632/oncotarget.9397
_version_ 1782463505825267712
author Jiang, Dingyuan
Huang, Xiaoxi
Geng, Jing
Dong, Run
Li, Shuhong
Liu, Zheng
Wang, Chen
Dai, Huaping
author_facet Jiang, Dingyuan
Huang, Xiaoxi
Geng, Jing
Dong, Run
Li, Shuhong
Liu, Zheng
Wang, Chen
Dai, Huaping
author_sort Jiang, Dingyuan
collection PubMed
description Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we investigated whether repeated challenge with PA induces persistent inflammation leading to sarcoidosis followed by PF in mice. Specifically, C57BL/6 mice were inoculated intraperitoneally and subjected to intratracheal challenge with PA, and then were booster-challenged with either PA or phosphate-buffered saline on day 28. Inflammation, granulomata, and features of fibrosis were evaluated every 7 days until day 70. Complete remission of lung granulomata was apparent on day 42 in the sarcoid-remission group. However, granulomata was present from days 21 to 70 in mice that received PA boosting. Inflammatory cell counts and Th1 cytokine levels in lung lavage fluids were elevated up to day 70. Furthermore, fibrotic changes in the lungs were observed around granulomatous and peribronchovascular regions after PA boosting. Taken together, these findings suggest that development of PF following sarcoidosis may result from continuous PA infection and inflammation. Repeated boosting with PA to induce PF might be a useful model for future studies of sarcoidosis-associated PF.
format Online
Article
Text
id pubmed-5085113
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-50851132016-10-31 Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes Jiang, Dingyuan Huang, Xiaoxi Geng, Jing Dong, Run Li, Shuhong Liu, Zheng Wang, Chen Dai, Huaping Oncotarget Research Paper: Pathology Pulmonary fibrosis (PF) associated with chronic sarcoidosis remains poorly understood, and no experimental model is currently available for this condition. Previous studies have shown that Propionibacterium acnes (PA) was associated with sarcoidosis and induced granuloma formation in mice. Here, we investigated whether repeated challenge with PA induces persistent inflammation leading to sarcoidosis followed by PF in mice. Specifically, C57BL/6 mice were inoculated intraperitoneally and subjected to intratracheal challenge with PA, and then were booster-challenged with either PA or phosphate-buffered saline on day 28. Inflammation, granulomata, and features of fibrosis were evaluated every 7 days until day 70. Complete remission of lung granulomata was apparent on day 42 in the sarcoid-remission group. However, granulomata was present from days 21 to 70 in mice that received PA boosting. Inflammatory cell counts and Th1 cytokine levels in lung lavage fluids were elevated up to day 70. Furthermore, fibrotic changes in the lungs were observed around granulomatous and peribronchovascular regions after PA boosting. Taken together, these findings suggest that development of PF following sarcoidosis may result from continuous PA infection and inflammation. Repeated boosting with PA to induce PF might be a useful model for future studies of sarcoidosis-associated PF. Impact Journals LLC 2016-05-17 /pmc/articles/PMC5085113/ /pubmed/27203210 http://dx.doi.org/10.18632/oncotarget.9397 Text en Copyright: © 2016 Jiang et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper: Pathology
Jiang, Dingyuan
Huang, Xiaoxi
Geng, Jing
Dong, Run
Li, Shuhong
Liu, Zheng
Wang, Chen
Dai, Huaping
Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
title Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
title_full Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
title_fullStr Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
title_full_unstemmed Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
title_short Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes
title_sort pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with propionibacterium acnes
topic Research Paper: Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085113/
https://www.ncbi.nlm.nih.gov/pubmed/27203210
http://dx.doi.org/10.18632/oncotarget.9397
work_keys_str_mv AT jiangdingyuan pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT huangxiaoxi pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT gengjing pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT dongrun pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT lishuhong pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT liuzheng pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT wangchen pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes
AT daihuaping pulmonaryfibrosisinamousemodelofsarcoidgranulomatosisinducedbyboosterchallengewithpropionibacteriumacnes